S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
pixel
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
pixel
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
pixel
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
pixel
pixel
Log in
NYSE:FMS

Fresenius Medical Care AG & Co. KGaA Stock Forecast, Price & News

$41.42
-0.19 (-0.46 %)
(As of 01/19/2021 12:00 AM ET)
Add
Compare
Today's Range
$41.34
Now: $41.42
$41.65
50-Day Range
$40.89
MA: $41.87
$43.32
52-Week Range
$29.17
Now: $41.42
$46.55
Volume301,118 shs
Average Volume434,721 shs
Market Capitalization$24.26 billion
P/E Ratio16.44
Dividend Yield1.20%
Beta1.21
Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides pharmacy services, vascular, cardiovascular, endovascular specialty, hospitalist, emergency, intensivist, medical cost management, ambulatory surgery center, health plan, urgent care, physician nephrology and cardiology, and ambulant treatment services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2019, it operated 3,994 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Fresenius Medical Care AG & Co. KGaA logo

MarketRank

Overall MarketRank

1.57 out of 5 stars

Analyst Opinion: 2.4Community Rank: 1.9Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone49-6172-608-2522
Employees120,659

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$19.58 billion
Cash Flow$5.49 per share
Book Value$24.83 per share

Profitability

Net Income$1.34 billion

Miscellaneous

Market Cap$24.26 billion
Next Earnings Date2/18/2021 (Estimated)
OptionableOptionable
$41.42
-0.19 (-0.46 %)
(As of 01/19/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive FMS News and Ratings via Email

Sign-up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Frequently Asked Questions

How has Fresenius Medical Care AG & Co. KGaA's stock price been impacted by Coronavirus (COVID-19)?

Fresenius Medical Care AG & Co. KGaA's stock was trading at $35.43 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, FMS shares have increased by 16.9% and is now trading at $41.42.
View which stocks have been most impacted by COVID-19
.

Is Fresenius Medical Care AG & Co. KGaA a buy right now?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. KGaA in the last year. There are currently 1 sell rating, 2 hold ratings, 10 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Fresenius Medical Care AG & Co. KGaA stock.
View analyst ratings for Fresenius Medical Care AG & Co. KGaA
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Fresenius Medical Care AG & Co. KGaA?

Wall Street analysts have given Fresenius Medical Care AG & Co. KGaA a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Fresenius Medical Care AG & Co. KGaA wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Fresenius Medical Care AG & Co. KGaA's next earnings date?

Fresenius Medical Care AG & Co. KGaA is scheduled to release its next quarterly earnings announcement on Thursday, February 18th 2021.
View our earnings forecast for Fresenius Medical Care AG & Co. KGaA
.

How were Fresenius Medical Care AG & Co. KGaA's earnings last quarter?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) released its earnings results on Thursday, October, 29th. The company reported $0.71 earnings per share for the quarter, beating analysts' consensus estimates of $0.66 by $0.05. The business had revenue of $5.16 billion for the quarter, compared to the consensus estimate of $5.55 billion. Fresenius Medical Care AG & Co. KGaA had a return on equity of 10.62% and a net margin of 7.38%.
View Fresenius Medical Care AG & Co. KGaA's earnings history
.

How often does Fresenius Medical Care AG & Co. KGaA pay dividends? What is the dividend yield for Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA declared an annual dividend on Thursday, August 13th. Investors of record on Monday, August 31st will be given a dividend of $0.7073 per share on Friday, September 11th. This represents a dividend yield of 1.64%. The ex-dividend date of this dividend is Friday, August 28th. This is a boost from Fresenius Medical Care AG & Co. KGaA's previous annual dividend of $0.66.
View Fresenius Medical Care AG & Co. KGaA's dividend history
.

Is Fresenius Medical Care AG & Co. KGaA a good dividend stock?

Fresenius Medical Care AG & Co. KGaA pays an annual dividend of $0.50 per share and currently has a dividend yield of 1.20%. The dividend payout ratio of Fresenius Medical Care AG & Co. KGaA is 19.76%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Fresenius Medical Care AG & Co. KGaA will have a dividend payout ratio of 16.95% next year. This indicates that Fresenius Medical Care AG & Co. KGaA will be able to sustain or increase its dividend.
View Fresenius Medical Care AG & Co. KGaA's dividend history.

What price target have analysts set for FMS?

14 brokers have issued 12 month price targets for Fresenius Medical Care AG & Co. KGaA's stock. Their forecasts range from $42.00 to $48.00. On average, they anticipate Fresenius Medical Care AG & Co. KGaA's share price to reach $45.13 in the next year. This suggests a possible upside of 8.9% from the stock's current price.
View analysts' price targets for Fresenius Medical Care AG & Co. KGaA
or view Wall Street analyst' top-rated stocks.

Are investors shorting Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA saw a decline in short interest in the month of December. As of December 31st, there was short interest totaling 379,900 shares, a decline of 20.3% from the December 15th total of 476,600 shares. Based on an average daily trading volume, of 190,000 shares, the days-to-cover ratio is presently 2.0 days.
View Fresenius Medical Care AG & Co. KGaA's Short Interest
.

Who are some of Fresenius Medical Care AG & Co. KGaA's key competitors?

What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. KGaA investors own include Energy Transfer (ET), Petra Diamonds Limited (PDL.L) (PDL), AT&T (T), Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), Merck & Co., Inc. (MRK), Abbott Laboratories (ABT), Chevron (CVX) and Ford Motor (F).

Who are Fresenius Medical Care AG & Co. KGaA's key executives?

Fresenius Medical Care AG & Co. KGaA's management team includes the following people:
  • Mr. Robert Maurice Powell Jr., Chairman of the Management Board & CEO of Fresenius Medical Care Mgmt AG (Age 65)
  • Ms. Helen Giza, CFO & Member of Management Board of Fresenius Medical Care Mgmt AG (Age 52)
  • Mr. Kent Wanzek, CEO of Global Mfg, Quality & Supply and Member of Management Board - Fresenius Medical Care Mgmt AG (Age 61)
  • Dr. Olaf Schermeier, CEO of Global R&D and Member of the Management Board - Fresenius Medical Care Mgmt AG (Age 48)
  • Mr. Harry de Wit, CEO of APAC & Member of Management Board - Fresenius Medical Care Mgmt AG (Age 58)
  • Mr. William Valle, CEO of North America & Member of Management Board at Fresenius Medical Care Mgmt AG (Age 60)
  • Dr. Katarzyna Mazur-Hofsäß Ph.D., CEO for EMEA & Member of Management Board - Fresenius Medical Care Mgmt AG (Age 57)
  • Ms. Rachel Clare Empey, Member of Supervisory Board - FMC Management AG (Age 44)
  • Dr. Franklin W. Maddux F.A.C.P., M.D., Global Chief Medical Officer & Member of Management board of Fresenius Medical Care Mgmt AG (Age 63)
  • Dr. Dominik Heger, Exec. VP and Head of Investor Relations, Strategic Devel. & Communications

What is Fresenius Medical Care AG & Co. KGaA's stock symbol?

Fresenius Medical Care AG & Co. KGaA trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."

Who are Fresenius Medical Care AG & Co. KGaA's major shareholders?

Fresenius Medical Care AG & Co. KGaA's stock is owned by a number of retail and institutional investors. Top institutional investors include Crossmark Global Holdings Inc. (0.01%).

Which major investors are buying Fresenius Medical Care AG & Co. KGaA stock?

FMS stock was bought by a variety of institutional investors in the last quarter, including Crossmark Global Holdings Inc..

How do I buy shares of Fresenius Medical Care AG & Co. KGaA?

Shares of FMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Fresenius Medical Care AG & Co. KGaA's stock price today?

One share of FMS stock can currently be purchased for approximately $41.42.

How big of a company is Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA has a market capitalization of $24.26 billion and generates $19.58 billion in revenue each year. The company earns $1.34 billion in net income (profit) each year or $2.53 on an earnings per share basis. Fresenius Medical Care AG & Co. KGaA employs 120,659 workers across the globe.

What is Fresenius Medical Care AG & Co. KGaA's official website?

The official website for Fresenius Medical Care AG & Co. KGaA is www.freseniusmedicalcare.com.

How can I contact Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA's mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The company can be reached via phone at 49-6172-608-2522 or via email at [email protected]

This page was last updated on 1/19/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.